Congress is debating a Democratic proposal, H.R.3, that would allow the federal government to negotiate prescription drug prices in an effort to lower costs.

Pharmaceutical giant Eli Lilly is partnering with patient advocacy group Susan G. Komen to expand resources to support Black women facing breast cancer in Indianapolis, Chicago and St. Louis. The spokeswoman for the new partnership is an Olympic athlete who has battled breast cancer.

The new price -- starting Jan. 1 -- will be about $80 per vial and comparable to how much a vial of Lilly's brand name Humalog insulin cost in 2008.

Starting Jan. 1, Lilly will drop the cost of its Insulin Lispro Injection -- the generic of its insulin Humalog -- by 40 percent, saving about $50 per vial.

An additional $5 million will go towards improving health equity through the Diabetes Impact Project, or DIP IN.

The announcement comes a few weeks after the Food and Drug Administration approved a treatment from rival Biogen despite warnings from the agency's independent advisers that it hasn't been shown to help slow the brain-destroying disease.

Global pharmaceutical company Eli Lilly is planning for employees working from home to return to their Indianapolis offices this summer. Officials say this is another step towards businesses returning to what operations were before the pandemic.

The Indianapolis-based global company is donating COVID-19 treatments to help severe cases in India and other countries struggling with the virus.

Overall, Lilly's net income fell 7 percent in the quarter to $1.35 billion, with adjusted earnings totaling $1.87 per share. Revenue grew 16 percent to $6.81 billion.

One of Indiana's most prominent corporations is criticizing an Indiana proposal that opponents maintain will make mail-in voting more difficult by requiring voters to submit identification numbers with their ballot applications.